Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79473 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Benzhydrol
CAS:Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormula:C13H12OColor and Shape:White Off-White PowderMolecular weight:184.08882Indole
CAS:Acridine (10-azaanthracene) and indole (2,3-benzopyrrole)Formula:C8H7NColor and Shape:White Crystalline PowderMolecular weight:117.05785Dipyridamole Related Compound C (2,2'-{[6-chloro-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]azanediyl}diethanol)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C20H30ClN7O2Color and Shape:Light Yellow SolidMolecular weight:435.21495Acetyl Simvastatin ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-(acetoxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate)
CAS:Lactones, nesoiFormula:C27H40O6Color and Shape:PowderMolecular weight:460.28249Trazodone Related Compound C (2-{3-[4-(4-Chlorophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C19H22ClN5O·HClColor and Shape:Off-White PowderMolecular weight:371.15129Desosaminylazithromycin ((2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-Ethyl-3,4,10,13-tetrahydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-dimethylamino-β-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C30H58N2O9Color and Shape:White Off-White PowderMolecular weight:590.41423Atomoxetine Related Compound C (N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormula:C17H21NO·HClColor and Shape:Off-White SolidMolecular weight:291.82Haloperidol Related Compound A (4,4'-Bis[4-(p-chlorophenyl)-4-hydroxypiperidino]butyrophenone)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C32H36Cl2N2O3Color and Shape:White PowderMolecular weight:567.564-Hydrazinylbenzenesulfonamide Hydrochloride
CAS:Sulfonamides, nesoiFormula:C6H9N3O2S·HClColor and Shape:Light Yellow Beige Crystalline PowderMolecular weight:223.68Estradiol Related Compound B (1,3,5(10),6-estratetraen-3,17β-diol)
CAS:Estrogens and progestinsFormula:C18H22O2Color and Shape:White Yellow Crystalline PowderMolecular weight:270.37Paclitaxel Related Compound B (10-deacetyl-7-epipaclitaxel)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C45H49O13NColor and Shape:White Off-White PowderMolecular weight:811.32039Phenylephrine Related Compound G ((R)-N-(2-Hydroxy-2-(3-hydroxyphenyl)ethyl)-N-methylglycine)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFormula:C11H15NO4Color and Shape:White PowderMolecular weight:225.10011Atenolol Related Compound D (2-[4-(3-Chloro-2-hydroxypropoxy)phenyl]acetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C11H14ClNO3Color and Shape:White SolidMolecular weight:243.06622Ranolazine Related Compound C (N-(2,6-Dimethylphenyl)-2-(piperazin-1-yl)acetamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C14H21N3OColor and Shape:White PowderMolecular weight:247.16846Azelastine Related Compound F (4-[4-(4-Chlorobenzyl)-1-oxophthalazin-2(1H)-yl]-1-methylazepane 1-oxide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C22H24ClN3O2Color and Shape:White SolidMolecular weight:397.9Adapalene Related Compound B (Methyl 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoate)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormula:C29H30O3Color and Shape:PowderMolecular weight:426.55Citalopram Related Compound G (3-[5-Chloro-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl]-N,N-dimethylpropan-1-amine hydrobromide)
Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C19H21ClFNO·HBrColor and Shape:White PowderMolecular weight:333.12957Salicylic Acid Related Compound A (4-hydroxybenzoic acid)
CAS:Carboxylic acids with phenol function but without other oxygen function, their anhydrides, halides, peroxides etc nesoiFormula:C7H6O3Color and Shape:White PowderMolecular weight:138.03169D-Valganciclovir (2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-methoxy]-3-hydroxypropyl D-valine ester monohydrochloride)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C14H22N6O5·HCIColor and Shape:Off-White PowderMolecular weight:494.07746Valsartan Related Compound B (N-butyryl-N-{[2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]methyl}-L-valine)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFormula:C23H27N5O3Color and Shape:White PowderMolecular weight:421.21139
